BioView blog
Every moment is an opportunity to push your research to its fullest potential. Through our BioView blog, we aspire to keep you informed on research developments, provide insights that support the success of your experiments, and inspire new ideas.
Controlling the spread of COVID-19 through rapid and scalable direct saliva testing
Date: January 4, 2021
Learn about the new direct saliva testing that offers a rapid, scalable, and contact-free option to the current nasal swab tests for COVID-19.
A cut above: the 2020 Nobel Prize in Chemistry is awarded for CRISPR/Cas9-mediated gene editing
Date: November 6, 2020
The scientific world is celebrating Emmanuelle Charpentier and Jennifer A. Doudna's remarkable work that led to precise genome editing technology, forever changing research in the life sciences.
TCR-seq methods: strengths, weaknesses, and rankings
Date: October 27, 2020
Categories: Research News
A new study by Dr. Encarnita Mariotti-Ferrandiz and her team compares commercial and academic NGS techniques for TCR repertoires.
In memory of Hermann Bujard (1934–2020)
Date: October 16, 2020
The global scientific community owes much to Hermann Bujard, a dedicated and passionate molecular biologist.
COVID-19 vaccine development: the quest to dethrone the evil King Coronavirus
Date: August 24, 2020
Categories: Exclusive content
Find out which types of SARS-CoV-2 vaccines are out there and how Takara Bio is joining the fight.
Know your enemy: finding certainty in uncertain times
Date: July 29, 2020
Categories: Research News
This blog highlights one of the first studies identifying and characterizing the novel coronavirus, ultimately contributing to the viral genome sequence being shared worldwide.
That’s Good Support: providing best-in-class online help
Date: July 20, 2020
Categories: Announcement
Learn why Takara Bio was awarded "Best Customer Service" two years in a row.
Joining the fight against antibiotic resistance
Date: June 23, 2020
Categories: Automation
Dr. Windi Muziasari, CEO of Resistomap, talks about how they are fighting the spread of antibiotic resistance genes and COVID-19 by providing robust tools for monitoring.
A faster path to analysis for monoclonal antibodies as therapeutic agents
Date: June 10, 2020
Categories: Research News
Researchers at Merck & Co., Inc. assess the use of rapid membrane processing for sample prep prior to PK studies in the drug development pipeline.
Overcoming technical challenges in extracellular vesicle research
Date: May 20, 2020
Categories: Translational Research
Dr. Daria Filanov, Chief Scientific Officer at Alpha Nano Tech, describes how her company helps their clients advance extracellular vesicle research.
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2023 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.
